Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Laser technologies improve medical treatments and outcomes.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Intense pulsed light is a safe and effective way to thin hair for East Asians after hairline surgery.

The study aims to find the best PRP dose for treating moderate carpal tunnel syndrome.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Bioluminescence imaging can track hair follicle cells and help study hair regrowth.

Low-intensity ultrasound can safely enhance hair regrowth by selecting the right frequency and intensity.

Standardizing light therapy methods could improve spinal cord injury treatment.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

The laser effectively removes hair for skin types IV and V but is less effective for type VI.

The laser therapy device effectively increased hair growth in people with androgenetic alopecia.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

The technique effectively improved upper eyelid symmetry in patients with mild and moderate blepharoptosis.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Combining fractional CO₂ laser with type III collagen improves acne scar treatment.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.